Cargando…

Comparison of the Clinical Features of Apical Hypertrophic Cardiomyopathy Versus Asymmetric Septal Hypertrophy in Korea

BACKGROUND: We sought to test whether patients with apical hypertrophic cardiomyopathy (APH) have different clinical features compared to those with typical asymmetric septal hypertrophy (ASH). METHODS: Among 32,534 patients who underwent routine echocardiography at Asan Medical Center from January...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hyun Suk, Song, Jae-Kwan, Song, Jong-Min, Kang, Duk-Hyun, Lee, Cheol Whan, Hong, Myeong-Ki, Kim, Jae-Joong, Park, Seong-Wook, Park, Seung-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891378/
https://www.ncbi.nlm.nih.gov/pubmed/16134764
http://dx.doi.org/10.3904/kjim.2005.20.2.111
_version_ 1782299369274343424
author Yang, Hyun Suk
Song, Jae-Kwan
Song, Jong-Min
Kang, Duk-Hyun
Lee, Cheol Whan
Hong, Myeong-Ki
Kim, Jae-Joong
Park, Seong-Wook
Park, Seung-Jung
author_facet Yang, Hyun Suk
Song, Jae-Kwan
Song, Jong-Min
Kang, Duk-Hyun
Lee, Cheol Whan
Hong, Myeong-Ki
Kim, Jae-Joong
Park, Seong-Wook
Park, Seung-Jung
author_sort Yang, Hyun Suk
collection PubMed
description BACKGROUND: We sought to test whether patients with apical hypertrophic cardiomyopathy (APH) have different clinical features compared to those with typical asymmetric septal hypertrophy (ASH). METHODS: Among 32,534 patients who underwent routine echocardiography at Asan Medical Center from January 2000 to December 2001, 305 patients (0.9%), who were finally diagnosed with hypertrophic cardiomyopathy (HCMP), were evaluated. The type of HCMP was classified according to the echocardiographic findings. RESULTS: ASH was the most frequent type (n=160, 53%, group I), and APH was the second most frequent (n=91, 30%, group II). Mean age (60.8±10 vs. 48.2±14 years, p<0.001) and prevalence of hypertension (32% vs. 19%, p=0.022) were significantly higher in group II than in group I. Family history of HCMP (4.4% vs. 0% p=0.043) and sudden cardiac death (8.8% vs. 1.1% p=0.014) was more prevalent in group I. During the follow-up period of 32.0± 37.2 months, cardiac events occurred at a significantly higher rate in group I (25.5% vs. 8.8%, p=0.003). CONCLUSION: APH comprises a significant proportion of HCMP in Korea and patients with APH show different clinical features compared to those with ASH.
format Online
Article
Text
id pubmed-3891378
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher The Korean Association of Internal Medicine
record_format MEDLINE/PubMed
spelling pubmed-38913782014-01-16 Comparison of the Clinical Features of Apical Hypertrophic Cardiomyopathy Versus Asymmetric Septal Hypertrophy in Korea Yang, Hyun Suk Song, Jae-Kwan Song, Jong-Min Kang, Duk-Hyun Lee, Cheol Whan Hong, Myeong-Ki Kim, Jae-Joong Park, Seong-Wook Park, Seung-Jung Korean J Intern Med Original Article BACKGROUND: We sought to test whether patients with apical hypertrophic cardiomyopathy (APH) have different clinical features compared to those with typical asymmetric septal hypertrophy (ASH). METHODS: Among 32,534 patients who underwent routine echocardiography at Asan Medical Center from January 2000 to December 2001, 305 patients (0.9%), who were finally diagnosed with hypertrophic cardiomyopathy (HCMP), were evaluated. The type of HCMP was classified according to the echocardiographic findings. RESULTS: ASH was the most frequent type (n=160, 53%, group I), and APH was the second most frequent (n=91, 30%, group II). Mean age (60.8±10 vs. 48.2±14 years, p<0.001) and prevalence of hypertension (32% vs. 19%, p=0.022) were significantly higher in group II than in group I. Family history of HCMP (4.4% vs. 0% p=0.043) and sudden cardiac death (8.8% vs. 1.1% p=0.014) was more prevalent in group I. During the follow-up period of 32.0± 37.2 months, cardiac events occurred at a significantly higher rate in group I (25.5% vs. 8.8%, p=0.003). CONCLUSION: APH comprises a significant proportion of HCMP in Korea and patients with APH show different clinical features compared to those with ASH. The Korean Association of Internal Medicine 2005-06 2005-06-30 /pmc/articles/PMC3891378/ /pubmed/16134764 http://dx.doi.org/10.3904/kjim.2005.20.2.111 Text en Copyright © 2005 The Korean Association of Internal Medicine http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Yang, Hyun Suk
Song, Jae-Kwan
Song, Jong-Min
Kang, Duk-Hyun
Lee, Cheol Whan
Hong, Myeong-Ki
Kim, Jae-Joong
Park, Seong-Wook
Park, Seung-Jung
Comparison of the Clinical Features of Apical Hypertrophic Cardiomyopathy Versus Asymmetric Septal Hypertrophy in Korea
title Comparison of the Clinical Features of Apical Hypertrophic Cardiomyopathy Versus Asymmetric Septal Hypertrophy in Korea
title_full Comparison of the Clinical Features of Apical Hypertrophic Cardiomyopathy Versus Asymmetric Septal Hypertrophy in Korea
title_fullStr Comparison of the Clinical Features of Apical Hypertrophic Cardiomyopathy Versus Asymmetric Septal Hypertrophy in Korea
title_full_unstemmed Comparison of the Clinical Features of Apical Hypertrophic Cardiomyopathy Versus Asymmetric Septal Hypertrophy in Korea
title_short Comparison of the Clinical Features of Apical Hypertrophic Cardiomyopathy Versus Asymmetric Septal Hypertrophy in Korea
title_sort comparison of the clinical features of apical hypertrophic cardiomyopathy versus asymmetric septal hypertrophy in korea
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891378/
https://www.ncbi.nlm.nih.gov/pubmed/16134764
http://dx.doi.org/10.3904/kjim.2005.20.2.111
work_keys_str_mv AT yanghyunsuk comparisonoftheclinicalfeaturesofapicalhypertrophiccardiomyopathyversusasymmetricseptalhypertrophyinkorea
AT songjaekwan comparisonoftheclinicalfeaturesofapicalhypertrophiccardiomyopathyversusasymmetricseptalhypertrophyinkorea
AT songjongmin comparisonoftheclinicalfeaturesofapicalhypertrophiccardiomyopathyversusasymmetricseptalhypertrophyinkorea
AT kangdukhyun comparisonoftheclinicalfeaturesofapicalhypertrophiccardiomyopathyversusasymmetricseptalhypertrophyinkorea
AT leecheolwhan comparisonoftheclinicalfeaturesofapicalhypertrophiccardiomyopathyversusasymmetricseptalhypertrophyinkorea
AT hongmyeongki comparisonoftheclinicalfeaturesofapicalhypertrophiccardiomyopathyversusasymmetricseptalhypertrophyinkorea
AT kimjaejoong comparisonoftheclinicalfeaturesofapicalhypertrophiccardiomyopathyversusasymmetricseptalhypertrophyinkorea
AT parkseongwook comparisonoftheclinicalfeaturesofapicalhypertrophiccardiomyopathyversusasymmetricseptalhypertrophyinkorea
AT parkseungjung comparisonoftheclinicalfeaturesofapicalhypertrophiccardiomyopathyversusasymmetricseptalhypertrophyinkorea